Scholarly Index
Antonio C. Wolff
Johns Hopkins University; 58,077 total citations; 671 total publications; best world rank #60
Johns Hopkins University
58,077Total citations
671Total publications
98H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 74 | US 40 | 99.73 |
| HER2/EGFR in Cancer Research | Lifetime | 60 | US 33 | 99.68 |
| Cancer Treatment and Pharmacology | Lifetime | 127 | US 72 | 99.58 |
| Advanced Breast Cancer Therapies | Lifetime | 77 | US 39 | 99.31 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 202 | US 114 | 95.76 |
| Cancer survivorship and care | Lifetime | 770 | US 359 | 95.85 |
| Economic and Financial Impacts of Cancer | Lifetime | 550 | US 350 | 94.68 |
| Cancer-related cognitive impairment studies | Lifetime | 650 | US 340 | 88.36 |
| Breast Cancer Treatment Studies | 2021-2025 | 85 | US 30 | 98.80 |
| HER2/EGFR in Cancer Research | 2021-2025 | 103 | US 36 | 98.41 |
| Advanced Breast Cancer Therapies | 2021-2025 | 177 | US 66 | 96.90 |
| Cancer Treatment and Pharmacology | 2021-2025 | 302 | US 107 | 94.02 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 671 | US 217 | 91.22 |
| Cancer survivorship and care | 2021-2025 | 591 | US 236 | 90.55 |
| BRCA gene mutations in cancer | 2021-2025 | 848 | US 367 | 82.97 |
| Cancer-related cognitive impairment studies | 2021-2025 | 318 | US 140 | 82.17 |
| Male Breast Health Studies | 2021-2025 | 244 | US 94 | 32.67 |